4.89
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Using R and stats models for Serina Therapeutics Inc. forecastingWall Street Watch & Expert Curated Trade Ideas - newser.com
What earnings revisions data tells us about Serina Therapeutics Inc.2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Serina Therapeutics CSO Randall Moreadith sells $22495 in stock By Investing.com - Investing.com Australia
Will Serina Therapeutics Inc. stock maintain growth storyEarnings Summary Report & Community Driven Trade Alerts - newser.com
Backtesting results for Serina Therapeutics Inc. trading strategies2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
Serina Therapeutics CSO Randall Moreadith sells $22495 in stock - Investing.com
How dovish Fed policy supports Serina Therapeutics Inc. (2BO) stockJuly 2025 Volume & Community Consensus Picks - newser.com
How Serina Therapeutics Inc. (2BO) stock performs in easing cyclesDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Is Serina Therapeutics Inc. stock supported by free cash flowJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Serina Therapeutics Inc. stock daily chart insightsJuly 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Using fundamentals and technicals on Serina Therapeutics Inc.Analyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
What does recent volatility data suggest for Serina Therapeutics Inc.July 2025 Movers & Daily Volume Surge Signals - newser.com
Applying Wyckoff theory to Serina Therapeutics Inc. stockQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Technical analysis overview for Serina Therapeutics Inc. stockJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Serina Therapeutics Launches Enhanced Corporate - GlobeNewswire
Phase 1b n=88 — Serina Therapeutics launches enhanced communications platform to support SER-252 trial - Stock Titan
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease - Sahm
Serina Therapeutics says submits IND to FDA, receives HREC approval in Australia for SER-252SEC filing - MarketScreener
Serina Therapeutics Draws First $5 Million Funding Tranche - GlobeNewswire
$5M tranche: Serina advances SER-252—IND filed, HREC approval; global registrational trial to start Q4 2025 - Stock Titan
Is Serina Therapeutics Inc. stock overpriced at current multiplesChart Signals & Stock Timing and Entry Methods - newser.com
Strategies to average down on Serina Therapeutics Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com
자본화:
|
볼륨(24시간):